Advertisement Beike Biotech to open new stem cell storage facility in China - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Beike Biotech to open new stem cell storage facility in China

Shenzhen Beike Biotechnology has started outfitting its 21,500 square foot comprehensive medical stem cell storage and processing facility in eastern China.

The stem cell storage facility will initially provide stem cell banking for human umbilical cord blood stem cells, placenta stem cells, amniotic membrane stem cells, bone marrow stem cells, and later will also be able to house induced pluripotent stem cells.

Initially, the facility will be used primarily for private banking of stem cells by individuals, but as the number of samples increases, it will focus on public banking for medical facilities with the aim of allowing Beike to become a global supplier for patients in need of stem cell transplants.

Jiangsu Beike Biotechnology, a subsidiary of Shenzhen Beike Biotechnology has been established to manage the facility.

The stem cell storage facility, which is set to be fully functional by year end 2008, is located next to the 15,000 square foot Jiangsu Beike Biotechnology office building, which already houses a showroom showcasing Beike’s technologies and treatments.